Rexam adds manufacturing capabilities

Device manufacturer Rexam Healthcare has announced a €20 million expansion of its manufacturing operations at its site in Le Tréport, France, giving the site a total workspace of 5200 sq m. Rexam will manufacture the new Advancia nasal spray pump and other drug delivery devices at Le Tréport. The company says that it plans to hire 50 new employees, bringing the total to 250.

The facility’s new 2900 sq m clean room is scheduled to open in November, with the rest of the new facility fully opened by early 2014.

Read the Rexam press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan